Contraceptive Use Before and After Gastric Bypass: a Questionnaire Study by Charlotte Ginstman et al.
ORIGINAL CONTRIBUTIONS
Contraceptive Use Before and After Gastric Bypass:
a Questionnaire Study
Charlotte Ginstman & Jessica Frisk & Johan Ottosson &
Jan Brynhildsen
Published online: 6 March 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Background At present, women are recommended to avoid
pregnancy 12–18 months after bariatric surgery. Our aim in
this study was to describe patterns of contraceptive use before
and after gastric bypass in Sweden, and to describe the con-
traceptive counseling given preoperatively to women under-
going gastric bypass.
Methods In October 2012, a questionnaire was sent to 1000
Swedish women who all had undergone gastric bypass during
2010. The women had been included in the Scandinavian
Obesity Surgery Register at time of surgery. The main out-
come measures were patterns of use of contraception before
and after bariatric surgery.
Results The response rate was 57 %. The most commonly
used contraceptive methods were intrauterine devices, 29 %
preoperatively and 26 % postoperatively even though there
was a postoperative switch from the copper intrauterine device
to the levonorgestrel intrauterine system. Thirty percent did
not use any contraceptive during the first 12 months after
surgery. Sixty percent of the responders were aware of the
recommendations to avoid pregnancy after surgery.
Conclusions Many women who undergo bariatric surgery are
not using any contracept ive method despi te the
recommendation that they should avoid pregnancy for at least
12 months. There is a great need to improve contraceptive
counseling for this growing group of women.
Keywords Gastric bypass . Pregnancy . Contraception .
Obesity
Introduction
Fifty-one percent of the adults in Sweden have been reported
to be either overweight or obese. The proportion of obese
Swedish women, i.e., with BMI >30 kg/m2 (BMI=body mass
index) has increased from 11 to 14 % between 2004 and 2012
[1]. Bariatric surgery is considered to be the most effective
treatment for morbid obesity [2], and the number of operations
in Sweden has increased dramatically from nearly 1000 in
2004 to 7700 in 2013 [3]. The number of operations per-
formed as a percentage of the total population is relatively
high in Sweden, 0.09 %, in comparison with Japan
0.0001 % or USA/Canada 0.03 % [4]. Ninety-two percent of
all bariatric surgery in Sweden is publically financed. Surgery
is offered if no contraindications are present to those seeking
help with BMI >35 kg/m2. The indication for bariatric surgery
is even stronger if a concomitant disorder such as diabetes,
hypertension, joint disease, and severe sleep apnea is present.
The leading surgical technique is gastric bypass (Roux-en-Y
gastric bypass, RYGB), which constitutes 92 % of all bariatric
surgery in Sweden [3]. Women constitute 76 % of all patients
undergoing gastric bypass in Sweden, and the median age for
patients is 41 years [3]. Women undergoing bariatric surgery in
Sweden as well as in other Western countries including the USA
aremost often advised not to become pregnant for 12–24months
postoperatively to avoid potential risks of fetal complications
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such as an increased risk of premature birth and children born
small for gestational age [5–7] and to avoid suboptimal weight
loss [8, 9]. Children born by RYGB mothers have a higher inci-
dence of lower birthweight (SGA, small for gestational age),
but there does not seem to be an increased risk of
malformations in pregnancies following surgery [10].
Kjaer et al., however, showed no differences in pregnan-
cy outcomes between children born within or after the
first postoperat ive year [11]. Theoretically, the
malabsorptive intestinal surgical procedures used may af-
fect the absorption of medicine taken orally [12]. If, and
how, the absorption of oral contraceptives is affected by
the gastric bypass method has not been studied. Victor
et al. in 1987 found significantly lower plasma levels of
both norethisterone and levonorgestrel postoperatively,
suggesting a reduced absorptive capacity for progesto-
gens 1 to 3 years after jejunoileal bypass [13]. However,
this procedure is much more extensive than gastric by-
pass. Retrospective studies [14, 15] have indicated a
small increase in risk of contraceptive failure in obese
women, but this could not be confirmed in a prospective
study [16]. A small study from the USA showed that
16 % of the women who underwent bariatric surgery
did not use effective contraceptive methods despite their
knowledge of the importance of avoiding pregnancy dur-
ing 12–18 months postoperatively [17]. To our knowl-
edge, this is the only published study concerning this
matter. We aimed to in a larger sample describe how
women having bariatric surgery perceived the contracep-
tive counseling they were given before the procedure and
to determine patterns of contraceptive use before and
after the surgery in these women.
Methods
The Scandinavian Obesity Surgery Register (SOReg)
provided names and personal identification numbers of
1000 women aged 18–45 years, who had undergone
bariatric surgery in Sweden during 2010. Correct ad-
dresses could be retrieved to 987 of these women, and
a postal questionnaire was sent to these women. The
questionnaire comprised questions regarding educational
level, smoking habits, pre- and postoperative weight,
and history of childbirth and pregnancies both before
and after the operation. Other questions concerned pre-
vious and present contraceptive use, contraceptive
counseling, and recommendations concerning avoidance
of pregnancy after bariatric surgery. We also asked ques-
tions regarding type and frequency of stool as frequent, loose
stool might affect uptake of pharmacological agents. More-
over, questions on oophorectomy and hysterectomy were in-
cluded. Data on comorbidity were retrieved from SOReg.
Validation Procedure The questionnaire was validated
with a Bthink-aloud^ cognitive interviewing technique
[18]. Six women who all recently had undergone gastric
bypass answered the questionnaire orally, face to face,
together with one of the researchers (CG), and all com-
ments on the questionnaire was noted. This procedure
identified some questions that needed remodeling. After
modification of the questionnaire, the validity was con-
sidered as good.
For comparison, SOReg provided preoperative data on
smoking habits, weight, and BMI.
The questionnaires were coded, which enabled us to send a
reminder to thosewomenwho had not answered after 4weeks,
and a second reminder was sent after another 4 weeks. When
the codes had been eliminated, the questionnaires were opti-
cally scanned into the computer. Optical scanning was
checked manually, and when the first 10 questionnaires had
shown total agreement between optical and manual reading,
the procedure was accepted.
Since all women did not answer every question, some of
the results have different numbers of participants. Proportions
may sum >100 % in cases where participants were permitted
to choose more than one option.
Statistics
SPSS version 21.0 was used to analyze data, mostly in forms
of descriptive statistics. Chi-square test was used for compar-
isons between groups.
Results
In total, 563 women answered the questionnaire, and conse-
quently, the response rate was 57 %. Two women returned a
blank questionnaire. Sixty-four percent had the operation
more than 2 but less than 3 years earlier. The remaining
36 % had the surgery between 1 and 2 years earlier. Nineteen
percent had never been pregnant, and 28 % were nulliparous.
Median weight before and after surgery was 122 and 75 kg,
respectively (Table 1).
There were no differences in weight loss during the first
postoperative year in relation to the contraceptive method the
women used during this time (data not shown).
Sixty-seven percent of the women used some kind of con-
traceptive method preoperatively (Table 2). Eighty percent of
these women were satisfied with their preoperative contracep-
tive method.
Progestin-only pills were the most commonly used oral
contraceptive during the preoperative period. The use of var-
ious oral contraceptives significantly declined after surgery,
but approximately 10 % were still using an oral contraceptive
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at the time of answering the questionnaire, i.e., more than
1 year after surgery (Table 2). Intrauterine contraception was
the most commonly used method both before and after sur-
gery. A trend to a shift from use of copper intrauterine devices
in favor of levonorgestrel intrauterine systems was noted,
however not significant (Table 2).
Almost every fourth woman (24.8 %) actively stated that
she did not receive any advice that she should avoid pregnan-
cy postoperatively, and 14.8 % did not remember whether or
not they had received such advice or not. A majority (96.8 %)
of the women who received information had been told they
should avoid pregnancy for 12–24 months after surgery. The
main sources of this information were midwives or gynecol-
ogists. The women stated that they had to arrange an appoint-
ment themselves. Eighteen percent stated they could have
benefited from more contraceptive counseling at the time of
surgery.
Almost one third of the women had not used any contra-
ception at all during the first year following surgery. Among
the women who presently used contraception, a majority
(82 %) were satisfied with their contraceptive method
(Table 2).
Twenty-five percent had become pregnant after surgery,
and 12 % were actively trying to become pregnant when they
answered the questionnaire. Almost 3 % reported becoming
pregnant postoperatively in spite of using contraception prop-
erly, but from the information available, it was not possible to
determine what methods these women had used at the time of
conception or how far after the surgery it had happened. Avast
majority of the women (98%) had normal frequencies of stool
ranging from three times per day up to only every other day.
Table 1 Characteristics of the 563 women who answered the
questionnaire. The number may vary because all women did not answer
all questions. Values are presented as median (range) or numbers (%)
Characteristics
Age (years) 36 (22–43)
Preoperative weight (kg) 122 (80–200)
Present weight (kg) 75 (47–164)
Preoperative BMI (kg/m2) 43.6 (29.7–73.5)
Present BMI (kg/m2) 27.1 (18.4–64.1)
Parity 2 (0–6)
Current partner
None 100 (18 %)
No cohabitating partner 38 (6.8 %)
Cohabitating partner 419 (75.2 %)
Highest diploma
High school 45 (8.0 %)
College 365 (65.3 %)
Graduate school 149 (27.7 %)
Professional situation
Working 389 (72 %)
Unemployed 37 (6.9 %)
Student 33 (6.1 %)
Others (housewife, sick leave, parental leave) 81 (15.0 %)
BMI body mass index
Table 2 Contraceptive methods used before and after surgery
Contraceptivea 12 months before, n=563 1–2 years after, n=563 Sign.c 1–2 years after, n=563
n (%) n (%) n (%)
Longer-acting reversible contraceptives
Copper intrauterine device 77 (13.7) 61 (10.9) NS 40 (7.1)
Lng IUSb 86 (15.3) 104 (18.5) NS 108 (19.2)
Implant 21 (3.7) 23 (4.1) NS 14 (2.5)
Short-acting hormonal contraceptives
Any oral contraceptive 130 (23.1) 87 (15.5) p=0.001 53 (9.4)
Combined oral contraceptives 43 (7.6) 29 (5.2) NS 22 (3.9)
Desogestrel progestin-only pill 59 (10.5) 46 (8.2) NS 28 (5.0)
Other progestin only pills 28 (5.0) 12 (2.1) p=0.01 3 (0.5)
Vaginal ring 6 (1.1) 13 (2.3) NS 7 (1.2)
Patch 0 (0) 5 (0.9) 3 (0.5)
Other contraceptives
Depo-Provera® 34 (6.0) 32 (5.7) NS 29 (5.2)
Condoms/other 110 (19.5) 109 (19.4) NS 78 (13.7)
None 182 (32.3) 168 (29.9) NS 210 (37.2)
a Participants could choose more than one option if they had changed method during the given period of time
b Levonorgestrel intrauterine system
c 12 months prior to surgery vs. 12 months postsurgery. Chi-square test
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Discussion
This study reflects the experience of a large sample of women of
fertile age who had undergone bariatric surgery. A substantial
number of these women stated that they had received insufficient
advice about avoiding pregnancy. Amajority also stated that they
received no or insufficient contraceptive counseling.
The Swedish guidelines recommend avoiding the combina-
tion of obesity and use of combined hormonal contraceptives
[19], as this has been shown to increase the risk of venous throm-
boembolism [20–22]. Also, the American College of Obstetri-
cians and Gynecologists (ACOG) state that due to the increased
thromboembolic risk in obese women Bconsideration should be
given to progestin-only and intrauterine methods when counsel-
ing obese women regarding contraceptive choices^ [23]. It is
therefore noteworthy and alarming that almost every tenth wom-
an had used combined hormonal contraceptives at some time
within 1 year prior to surgery. The percentage of women using
combined hormonalmethods was even higher, 27%, in theUSA
in the study by Mody et al. [17].
Sixty-seven percent of the women used any contraceptive
method which is slightly lower than in the general Swedish
population (72 %, Helena Kopp-Kallner et al., Karolinska
Institutet, Stockholm, unpublished data). The use of oral con-
traceptives remains relatively high after gastric bypass, which
is surprising, since present knowledge of how surgery affects
the uptake and effect of oral contraceptives after surgery is
limited, but previous data indicate a decrease in the absorption
of oral contraceptives. Further pharmacokinetic studies are
needed in this field to provide a basis for improving contra-
ceptive counseling for this group.
Smoking was reported equally frequent postoperatively
(16 %) as compared with preoperative data from SOReg
(13.5 %), which indicates that the preoperative smoke restric-
tion is only temporarily followed.
A substantial number of the women did not receive any
contraceptive counseling. These findings are similar to those
of Mody et al. [17] and emphasize the need for improved
contraceptive counseling for women undergoing gastric by-
pass surgery, both in a European and American perspective.
Since obese women often suffer from obesity-related infertil-
ity, it was not surprising that the overall usage of contraception
declined 1 year after surgery. This pregnancy-wish may also
partly explain why 30 % did not use contraception at all during
the 12-month period postoperatively, a percentage almost double
with what was reported earlier byMody et al. [17]. Failure to use
contraception may also be explained by the fact that as many as
25 % cannot recall receiving this recommendation.
The number of women becoming pregnant after gastric by-
pass in spite of contraceptive use does not seem to be higher than
expected in any group of women during the 1 to 2 years of
follow-up. We found no difference in weight loss after surgery
between women using different kinds of contraceptives. These
observations must be viewed with caution as the groups differed
in size range between 5 and more than 100.
This study reflects the contraceptive use and presents in-
formation on the insufficient contraceptive counseling in rela-
tion to bariatric surgery in a large sample of obese women
using a validated questionnaire. To our knowledge, this is
the largest study concerning contraceptive counseling for
women who undergo bariatric surgery. Some of the informa-
tion from the questionnaire could be compared with the pro-
spectively gathered data in SOReg, and the self-reported pre-
operative BMI with a median of 43.6 (Table 1) correlated well
with data of preoperative BMI from SOReg (median 42.3).
The low response rate, however, suggests that the interpre-
tationsmust be viewedwith caution. Dropout analysis showed
that the responding group was similar to the non-responding
group of women in terms of preoperative BMI, comorbidity,
and age. According to data from SOReg, there were slightly
more smokers in the non-responding group, but we do not
believe this has biased our results.
Still many authorities recommend a woman undergoing
bariatric surgery to avoid pregnancy the first year (s) after
the operation. However, a recent Danish study [24] was not
able to demonstrate a relation between the Bsurgery-to-
conception^ interval and the fetal outcome, and it might be
speculated that the current recommendations might be revised.
Rapid weight loss have been shown to increase the serum
levels of persistent organic pollutants, normally stored in body
fat [25], which theoretically could be a strong reason to post-
pone pregnancy until the weight is stabilized. But irrespective
if a revision will be necessary or not, both the present study
and the previous study by Mody et al. [15] show a need of
improved contraceptive counseling for obese women under-
going bariatric surgery.
Conclusion
We identified a great need to provide improved contraceptive
counseling for this growing group of women undergoing gas-
tric bypass surgery. Health-care professionals involved in bar-
iatric surgery need to emphasize the recommendations
concerning contraception and, if needed, refer the patients to
a gynecologist preoperatively for contraceptive counseling.
We suggest that standard written information on advice
concerning postoperative pregnancies/contraception should
be handed out by the operating center to every individual
considering undergoing bariatric surgery.
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